4.7 Article

Whole-Exome Sequencing of 2,000 Danish Individuals and the Role of Rare Coding Variants in Type 2 Diabetes

Journal

AMERICAN JOURNAL OF HUMAN GENETICS
Volume 93, Issue 6, Pages 1072-1086

Publisher

CELL PRESS
DOI: 10.1016/j.ajhg.2013.11.005

Keywords

-

Funding

  1. Miller Research Institute at the University of California, Berkeley
  2. Danish Council for Independent Research
  3. National Science Foundation [DBI-1103639]
  4. Lundbeck Foundation
  5. Novo Nordisk Foundation
  6. Danish Council for Independent Research Medical Sciences
  7. Danish Research Council
  8. Danish Centre for Health Technology Assessment
  9. Novo Nordisk
  10. Research Foundation of Copenhagen County
  11. Ministry of Internal Affairs and Health
  12. Danish Heart Foundation
  13. Danish Pharmaceutical Association
  14. Augustinus Foundation
  15. Ib Henriksen Foundation
  16. Becket Foundation
  17. Danish Diabetes Association
  18. Villum Fonden [00007171] Funding Source: researchfish

Ask authors/readers for more resources

It has been hypothesized that, in aggregate, rare variants in coding regions of genes explain a substantial fraction of the heritability of common diseases. We sequenced the exomes of 1,000 Danish cases with common forms of type 2 diabetes (including body mass index > 27.5 kg/m(2) and hypertension) and 1,000 healthy controls to an average depth of 56x. Our simulations suggest that our study had the statistical power to detect at least one causal gene (a gene containing causal mutations) if the heritability of these common diseases was explained by rare variants in the coding regions of a limited number of genes. We applied a series of gene-based tests to detect such susceptibility genes. However, no gene showed a significant association with disease risk after we corrected for the number of genes analyzed. Thus, we could reject a model for the genetic architecture of type 2 diabetes where rare nonsynonymous variants clustered in a modest number of genes (fewer than 20) are responsible for the majority of disease risk.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available